Medical device tax: House Ways & Means considers arguments for repeal coverage of the medical device tax

Opponents of the medical device tax returned this week to the House Ways & Means Committee to decry the 2.3% levy imposed by the Affordable Care Act.

In opening remarks for today’s hearing, Rep. Charles Boustany (R-La.) called the device tax "particularly destructive," blaming the levy for workforce cuts and delays in new product development.

Boustany appeared to agree with previous comments made by medical device makers, putting repeal of the medical device tax in the context of a larger tax reform measure. He put other healthcare reform taxes in the same boat, with their best chance of repeal tied to comprehensive corporate tax reforms.

"Any tax measures will be considered, most likely, in the context of fundamental tax reform," Boustany told reporters after today’s hearing, Healthwatch reported.

Medical device representatives attending the hearing urged Congress to repeal the tax, warning that "is threatening America’s leadership position."

"If we lose America’s leadership position in medical technology innovation – and the great jobs and all the other benefits that come with it – we will never get it back, and countless communities will never look the same," Dan Moore, chairman of the Medical Device Manufacturers Assn. and president & CEO of Cyberonics, said in prepared remarks. "None of us want to have to explain to our children one day why they don’t have the opportunity to work in the same dynamic industry as their parents did, focused on improving the human condition."

"I urge you to support the repeal of the medical device tax which is harming innovation, job creation, and most importantly, patient care," Moore added.

Rep. Boustany decried many of the taxes contained in President Barack Obama’s landmark healthcare reform act, among them insurance taxes and the employer mandate, but took time to emphasize the potential harm the medical device tax may pose to companies and the U.S.’s lead in global medical innovation.

"The new medical device tax is particularly destructive, as it targets one of the few remaining industries where America continues to lead the world in innovation," Boustany said in opening remarks. "This is an industry in which companies often go years without making a profit, hoping to survive long enough to reach profitability and introduce innovative life-saving medical products. But the new tax hits employers regardless of profitability, and has already resulted in layoffs and additional delays in new products reaching the market."

The House Ways & Means Committee has been favorable to medical device tax repeal efforts in the past. In May 2012 the committee swiftly passed a repeal bill in a 23-to-11 vote, sending the bill to a floor vote, but the decision wasn’t without conflict.

Committee Democrats at the time expressed concern about how to make up for the $30 billion the medtech levy is projected to raise over 10 years, but were outvoted by the majority, with 2 of their own joining Republicans in supporting repeal.

The issue of a so-called "pay-for" to make up for the lost revenue the medical device tax is projected to generate has been a sticking point for many Democrats, hampering repeal efforts in the Dem-led Senate.

A pair of medtech tax repeal bills introduced last month have 203 co-sponsors in the House of Representatives, 25 of them Democrats, and 28 co-sponsors in the Senate, 4 of them Democrats.

Lobbying groups such as MDMA and AdvaMed have vowed to continue fighting to repeal the tax, which took effect at the start of the year.

AdvaMed said late last month that it’s 2013 agenda demonstrated its intention to "double down" on efforts to repeal the levy.

MDMA president & CEO Mark Leahey said in prepared comments today that those efforts are gaining traction among lawmakers.

"While each and every day is a challenge for medical technology innovators to balance the impact of the device tax with the goals of improving health care, bipartisan momentum continues to build for efforts to repeal this policy," Leahey said. "One job lost is one too many, and the thousands lost to date are devastating. As the real world consequences of the tax surface, more Members of Congress are taking notice."

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply